123 results
Keyword Paclitaxel Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Apealea (updated)
paclitaxel, Ovarian Neoplasms
Date of authorisation: 20/11/2018, Revision: 1, Authorisedauthorisation) Apealea paclitaxel On 20 September 2018, the … substance of Apealea is paclitaxel, an antineoplastic agent that … ‘taxanes’ (ATC code: L01CD01). Paclitaxel blocks a stage of cell division … -
List item
Human medicine European public assessment report (EPAR): Abraxane
paclitaxel, Breast Neoplasms, Pancreatic Neoplasms, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 10/01/2008, Revision: 23, AuthorisedAbraxane, INN-paclitaxel 30 Churchill Place … for the public Abraxane paclitaxel This document is a summary … contains the active substance paclitaxel attached to a human protein … -
List item
Human medicine European public assessment report (EPAR): Paxene
paclitaxel, Sarcoma, Kaposi, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Breast Neoplasms
Date of authorisation: 19/07/1999, Revision: 14, WithdrawnPublic statement on Paxene (paclitaxel) Withdrawal of the marketing … medicinal product Paxene, paclitaxel, which had been approved for … EMEA/H/C/216 Paxene paclitaxel EPAR summary for the … -
List item
Human medicine European public assessment report (EPAR): Pazenir
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,
, Authorised
paclitaxel … paclitaxel … paclitaxel … -
List item
Human medicine European public assessment report (EPAR): Avastin
bevacizumab, Carcinoma, Non-Small-Cell Lung, Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Carcinoma, Renal Cell
Date of authorisation: 12/01/2005, Revision: 50, Authorisedused in combination with paclitaxel (an anticancer medicine belonging … combination with the taxane paclitaxel. This follows a review1 of … cancer, in combination with paclitaxel or capecitabine; advanced … -
List item
Human medicine European public assessment report (EPAR): Mvasi
bevacizumab, Carcinoma, Renal Cell, Peritoneal Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms
Date of authorisation: 14/01/2018,
, 
, Revision: 3, Authorised
medicines carboplatin and paclitaxel. The cancer responded to … medicines carboplatin and paclitaxel. The cancer responded to treatment … -
List item
Human medicine European public assessment report (EPAR): Cyramza
Ramucirumab, Stomach Neoplasms
Date of authorisation: 19/12/2014,, Revision: 7, Authorised
combination with another medicine, paclitaxel, or on its own if the combination … if the combination with paclitaxel is not appropriate, in patients … given in combination with paclitaxel, the recommended dose is 8 … -
List item
Human medicine European public assessment report (EPAR): Zirabev (updated)
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 14/02/2019,, , Revision: 1, Authorised
medicines carboplatin and paclitaxel. The cancer responded to treatment … -
List item
Human medicine European public assessment report (EPAR): Herceptin
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 28/08/2000, Revision: 34, Authorisedanticancer medicines: with paclitaxel or docetaxel, or with an … Herceptin in combination with paclitaxel or docetaxel in a total of … used in combination with paclitaxel or docetaxel, around half … -
List item
Human medicine European public assessment report (EPAR): Ogivri (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 12/12/2018,, , Revision: 1, Authorised
other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Keytruda
Pembrolizumab, Melanoma, Hodgkin Disease, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 17/07/2015,, Revision: 17, Authorised
Keytruda with carboplatin and paclitaxel or or nabpaclitaxel lived on average for 15.9 … placebo with carboplatin and paclitaxel or nabpaclitaxel. Patients in the Keytruda … -
List item
Human medicine European public assessment report (EPAR): Trazimera (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/07/2018,, , Revision: 2, Authorised
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Kanjinti (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 16/05/2018,, , Revision: 4, Authorised
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Mekinist
trametinib, Melanoma
Date of authorisation: 30/06/2014, Revision: 16, Authorisedmedicines dacarbazine or paclitaxel at controlling melanoma … patients given dacarbazine or paclitaxel. In an additional study … medicines dacarbazine or paclitaxel at controlling melanoma that … -
List item
Human medicine European public assessment report (EPAR): Ontruzant
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 15/11/2017,, , Revision: 3, Authorised
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Hycamtin
topotecan, Ovarian Neoplasms, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 12/11/1996, Revision: 29, Authorisedand compared Hycamtin with paclitaxel (another cancer medicine … compared with 14% of the paclitaxel patients (16 out of 114 … and compared Hycamtin with paclitaxel (another cancer medicine … -
List item
Human medicine European public assessment report (EPAR): Herzuma (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 08/02/2018,, , Revision: 5, Authorised
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Opdivo
nivolumab, Melanoma, Hodgkin Disease, Carcinoma, Renal Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 19/06/2015,, Revision: 24, Authorised
combination of carboplatin and paclitaxel). A third study in 906 adults … -
List item
Human medicine European public assessment report (EPAR): Iressa
gefitinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 24/06/2009, Revision: 12, Authorisedcombination of carboplatin and paclitaxel (other anticancer medicines … combination of carboplatin and paclitaxel (other anticancer medicines … -
List item
Human medicine European public assessment report (EPAR): Sirturo (updated)
bedaquiline fumarate, Tuberculosis, Multidrug-Resistant
Date of authorisation: 05/03/2014,, 
, 
, Revision: 15, Authorised
-
List item
Human medicine European public assessment report (EPAR): Docetaxel Zentiva (previously Docetaxel Winthrop) (updated)
docetaxel, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, Prostatic Neoplasms, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 20/04/2007, Revision: 30, Authorised -
List item
Human medicine European public assessment report (EPAR): Nerlynx (updated)
neratinib, Breast Neoplasms
Date of authorisation: 31/08/2018,, Revision: 1, Authorised
-
List item
Human medicine European public assessment report (EPAR): Orencia (updated)
Abatacept, Arthritis, Psoriatic, Arthritis, Juvenile Rheumatoid, Arthritis, Rheumatoid
Date of authorisation: 21/05/2007, Revision: 28, Authorised -
List item
Human medicine European public assessment report (EPAR): Prezista (updated)
darunavir, HIV Infections
Date of authorisation: 11/02/2007, Revision: 46, Authorised -
List item
Human medicine European public assessment report (EPAR): Thalidomide Celgene (previously Thalidomide Pharmion) (updated)
Thalidomide, Multiple Myeloma
Date of authorisation: 16/04/2008,, Revision: 23, Authorised